Equilibre

About:

Equilibre is a biopharmaceuticals corporation developing differentiated and novel therapeutic candidates.

Website: https://eqneuro.com/

Twitter/X: eqbiopharma

Description:

Equilibre is a biopharmaceuticals corporation developing differentiated and novel therapeutic candidates. Équilibre is founded upon advancing science to benefit patients. They are committed to delivering innovative treatments to millions of patients who experience conditions for which there are inadequate or nonexistent treatments.

Total Funding Amount:

$52.4M

Headquarters Location:

New York, New York, United States

Founded Date:

2020-06-01

Contact Email:

info(AT)eqneuro.com

Founders:

Samuel D. Waksal

Number of Employees:

11-50

Last Funding Date:

2022-12-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai